Athira Pharma, Inc. ATHA Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000950170-25-068040
cik 1620463
name ATHIRA PHARMA, INC.
sic 2836
countryba US
stprba WA
cityba BOTHELL
zipba 98011
bas1 18706 NORTH CREEK PARKWAY, SUITE 104
bas2
baph (425) 620-8501
countryma US
stprma WA
cityma BOTHELL
zipma 98011
mas1 18706 NORTH CREEK PARKWAY, SUITE 104
mas2
countryinc
stprinc
ein 453368487
former M3 BIOTECHNOLOGY, INC.
changed 20140924
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250509
accepted 2025-05-09 16:15:00.0
prevrpt 0
detail 1
instance atha-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-068040 20241231 Cash And Cash Equivalents At Carrying Value 48438000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2679000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20250331 Cash And Cash Equivalents At Carrying Value 26422000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Cash And Cash Equivalents At Carrying Value 4037000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= U S Government Agencies Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 49069000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Common Stock Shares Issued 39042445.0000 shares 0 us-gaap/2024
0000950170-25-068040 20250331 Earnings Per Share Basic -0.2300 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Earnings Per Share Diluted -0.6900 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Gain Loss On Sale Of Property Plant Equipment -7000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Increase Decrease In Operating Lease Liability -87000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent -5000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20250331 Other Nonoperating Income Expense 393000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Payments To Acquire Available For Sale Securities Debt 5911000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Short Term Investments 2837000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Stockholders Equity 4000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20241231 Stockholders Equity 4000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20241231 Stockholders Equity -406146000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20250331 Stockholders Equity 37330000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Accounts Payable Current 319000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Assets 58779000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Cash And Cash Equivalents At Carrying Value 77821000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 91215000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Costs And Expenses 27687000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Costs And Expenses 9536000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Earnings Per Share Basic -0.6900 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Earnings Per Share Diluted -0.2300 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Liabilities Current 13135000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Net Cash Provided By Used In Investing Activities 13041000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Operating Income Loss -9536000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Prepaid Expense And Other Assets Current 3183000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Share Based Compensation 2679000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20231231 Stockholders Equity -349000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20241231 Stockholders Equity 450982000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20241231 Other Assets Noncurrent 55000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1637000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1637000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20250331 Cash And Cash Equivalents At Carrying Value 13000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 78452000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Common Stock Shares Authorized 900000000.0000 shares 0 us-gaap/2024
0000950170-25-068040 20241231 Common Stock Shares Issued 39040945.0000 shares 0 us-gaap/2024
0000950170-25-068040 20241231 Common Stock Shares Outstanding 39040945.0000 shares 0 us-gaap/2024
0000950170-25-068040 20240331 Depreciation 242000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 General And Administrative Expense 5234000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -1155000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Operating Lease Liability Current 426000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Operating Lease Right Of Use Asset Amortization Expense 57000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 18957000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Stockholders Equity -335543000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20250331 Stockholders Equity -4000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20250331 Stockholders Equity 4000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20240331 Weighted Average Number Of Diluted Shares Outstanding 38321573.0000 shares 1 us-gaap/2024
0000950170-25-068040 20240331 Accretion Amortization Of Discounts And Premiums Investments 266000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Accrued Liabilities Current 12402000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2679000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Assets Current 54841000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Cash And Cash Equivalents At Carrying Value 30000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Money Market Funds; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20241231 Cash And Cash Equivalents At Carrying Value 29721000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20250331 Cash And Cash Equivalents At Carrying Value 20689000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities -3254000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Net Income Loss -26337000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20240331 Operating Income Loss -27687000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Operating Lease Right Of Use Asset 808000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent 212000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20250331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 2850000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Research And Development Expense 4302000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Restricted Cash Noncurrent 631000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Stockholders Equity 44841000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Stockholders Equity 452619000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20250331 Accretion Amortization Of Discounts And Premiums Investments 65000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 1000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Assets Current 39853000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Cash And Cash Equivalents At Carrying Value 16639000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Commercial Paper; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -12763000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Comprehensive Income Net Of Tax -26125000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Comprehensive Income Net Of Tax -9148000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares 1500.0000 shares 1 0000950170-25-068040 Equity Components= Common Stock;
0000950170-25-068040 20241231 Liabilities 13938000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Liabilities 6183000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Net Income Loss -9143000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20240331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent 212000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Other Nonoperating Income Expense 1350000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Payments To Acquire Available For Sale Securities Debt 10201000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Property Plant And Equipment Net 2444000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Research And Development Expense 21236000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Restricted Cash Noncurrent 631000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Retained Earnings Accumulated Deficit -415289000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Share Based Compensation 1637000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Shares Outstanding 38326652.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20241231 Shares Outstanding 39040945.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20250331 Shares Outstanding 39042445.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20250331 Short Term Investments 10248000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 Stockholders Equity 442418000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20250331 Weighted Average Number Of Diluted Shares Outstanding 39042445.0000 shares 1 us-gaap/2024
0000950170-25-068040 20240331 Weighted Average Number Of Shares Outstanding Basic 38321573.0000 shares 1 us-gaap/2024
0000950170-25-068040 20250331 Accrued Liabilities Current 4199000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Assets 43513000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 27053000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Common Stock Shares Authorized 900000000.0000 shares 0 us-gaap/2024
0000950170-25-068040 20240331 Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares 154049.0000 shares 1 0000950170-25-068040 Equity Components= Common Stock;
0000950170-25-068040 20241231 Liabilities And Stockholders Equity 58779000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Net Cash Provided By Used In Operating Activities -14665000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Prepaid Expense And Other Assets Current 3566000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20231231 Stockholders Equity 130188000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20231231 Stockholders Equity 4000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20231231 Stockholders Equity -309206000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20241231 Additional Paid In Capital Common Stock 450982000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Additional Paid In Capital Common Stock 452619000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -22016000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Common Stock Value 4000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Depreciation 243000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities -7655000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -353000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Net Cash Provided By Used In Investing Activities -7351000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Net Cash Provided By Used In Operating Activities -25804000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Net Income Loss -26337000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Operating Lease Liability Current 414000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Operating Lease Liability Noncurrent 691000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Operating Lease Right Of Use Asset Amortization Expense 65000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Property Plant And Equipment Net 2201000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Retained Earnings Accumulated Deficit -406146000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20231231 Stockholders Equity 439739000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-068040 20240331 Stockholders Equity -137000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20250331 Accounts Payable Current 867000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -4000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Cash And Cash Equivalents At Carrying Value 19394000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= Commercial Paper; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20241231 Cash And Cash Equivalents At Carrying Value 10297000.0000 USD 0 us-gaap/2024 Cash And Cash Equivalents= Cash Equivalents; Fair Value By Asset Class= U S Government Agencies Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0000950170-25-068040 20250331 Common Stock Shares Outstanding 39042445.0000 shares 0 us-gaap/2024
0000950170-25-068040 20250331 Common Stock Value 4000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20240331 General And Administrative Expense 6451000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Increase Decrease In Operating Lease Liability -100000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Liabilities And Stockholders Equity 43513000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Liabilities Current 5492000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Net Income Loss -9143000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20241231 Operating Lease Liability Noncurrent 803000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Operating Lease Right Of Use Asset 743000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Other Assets Noncurrent 85000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20250331 Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent -5000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Payments To Acquire Property Plant And Equipment 5000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20240331 Profit Loss -26337000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Profit Loss -9143000.0000 USD 1 us-gaap/2024
0000950170-25-068040 20250331 Restricted Cash Noncurrent 631000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20231231 Shares Outstanding 38172603.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-068040 20240331 Stockholders Equity 106742000.0000 USD 0 us-gaap/2024
0000950170-25-068040 20241231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-068040 20250331 Stockholders Equity -415289000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-068040 20250331 Weighted Average Number Of Shares Outstanding Basic 39042445.0000 shares 1 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Short Term Investments us-gaap/2024 0 0 monetary I D Short-Term Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Payments To Acquire Available For Sale Securities Debt us-gaap/2024 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares 0000950170-25-068040 1 0 shares D Issuance of Common Stock Upon Vesting of Restricted Stock Units, Shares Issuance of common stock upon vesting of restricted stock units, shares.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Restricted Cash Noncurrent us-gaap/2024 0 0 monetary I D Restricted Cash, Noncurrent Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Costs And Expenses us-gaap/2024 0 0 monetary D D Costs and Expenses Total costs of sales and operating expenses for the period.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2024 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Accretion Amortization Of Discounts And Premiums Investments us-gaap/2024 0 0 monetary D C Accretion (Amortization) of Discounts and Premiums, Investments The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-068040 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-068040 2 4 BS 0 H Short Term Investments us-gaap/2024 Short-term investments 0
0000950170-25-068040 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-068040 2 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-068040 2 7 BS 0 H Restricted Cash Noncurrent us-gaap/2024 Restricted cash 0
0000950170-25-068040 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-068040 2 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use asset 0
0000950170-25-068040 2 10 BS 0 H Other Assets Noncurrent us-gaap/2024 Other long-term assets 0
0000950170-25-068040 2 11 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-068040 2 14 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-068040 2 15 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued liabilities 0
0000950170-25-068040 2 16 BS 0 H Operating Lease Liability Current us-gaap/2024 Current operating lease liability 0
0000950170-25-068040 2 17 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-068040 2 18 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liability, less current portion 0
0000950170-25-068040 2 19 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-068040 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.0001 par value; 900,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; 39,042,445 and 39,040,945 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-068040 2 22 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0000950170-25-068040 2 23 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive (loss) income 0
0000950170-25-068040 2 24 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-068040 2 25 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0000950170-25-068040 2 26 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0000950170-25-068040 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0000950170-25-068040 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-068040 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-068040 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-068040 4 2 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-068040 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-068040 4 4 IS 0 H Costs And Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-068040 4 5 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0000950170-25-068040 4 6 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income, net 0
0000950170-25-068040 4 7 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-068040 4 8 IS 0 H Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Unrealized (loss) gain on available-for-sale securities 0
0000950170-25-068040 4 9 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive loss attributable to common stockholders 0
0000950170-25-068040 4 10 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share attributable to common stockholders, basic 0
0000950170-25-068040 4 11 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share attributable to common stockholders, diluted 0
0000950170-25-068040 4 12 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average shares used in computing net loss per share attributable to common stockholders, basic 0
0000950170-25-068040 4 13 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted 0
0000950170-25-068040 5 9 EQ 0 H Stockholders Equity us-gaap/2024 Beginning balance 0
0000950170-25-068040 5 10 EQ 0 H Shares Outstanding us-gaap/2024 Beginning balance, shares 0
0000950170-25-068040 5 11 EQ 0 H Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Shares 0000950170-25-068040 Issuance of common stock upon vesting of restricted stock units, shares 0
0000950170-25-068040 5 12 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0000950170-25-068040 5 13 EQ 0 H Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Unrealized gain on available-for-sale securities 0
0000950170-25-068040 5 14 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-068040 5 15 EQ 0 H Stockholders Equity us-gaap/2024 Ending balance 0
0000950170-25-068040 5 16 EQ 0 H Shares Outstanding us-gaap/2024 Ending balance, shares 0
0000950170-25-068040 6 2 CF 0 H Profit Loss us-gaap/2024 Net loss 0
0000950170-25-068040 6 4 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation 0
0000950170-25-068040 6 5 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0000950170-25-068040 6 6 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Non-cash lease expense 0
0000950170-25-068040 6 7 CF 0 H Accretion Amortization Of Discounts And Premiums Investments us-gaap/2024 Amortization of premiums and accretion of discounts on available-for-sale securities, net 1
0000950170-25-068040 6 8 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Loss on disposal of equipment 1
0000950170-25-068040 6 10 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current and long-term assets, net 1
0000950170-25-068040 6 11 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities 0
0000950170-25-068040 6 12 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease liability 0
0000950170-25-068040 6 13 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0000950170-25-068040 6 15 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2024 Purchases of available-for-sale securities 1
0000950170-25-068040 6 16 CF 0 H Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2024 Maturities of available-for-sale securities 0
0000950170-25-068040 6 17 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-068040 6 18 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash (used in) provided by investing activities 0
0000950170-25-068040 6 19 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net decrease in cash, cash equivalents and restricted cash 0
0000950170-25-068040 6 20 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, cash equivalents and restricted cash, beginning of period 0
0000950170-25-068040 6 21 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, cash equivalents and restricted cash, end of period 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.